BRIEF-Collegium Announces Authorized Agreement With Hikma Pharmaceuticals USA For Nucynta

+0.08%

+0.78%

-0.22%

-0.51%

Dow Jones Industrial Average DJI	42206.82	+0.08%
Collegium Pharmaceutical, Inc. COLL	29.83	+0.78%
S&P 500 index SPX	5967.84	-0.22%
NASDAQ IXIC	19447.41	-0.51%

April 29 (Reuters) - Collegium Pharmaceutical Inc COLL.O:

COLLEGIUM ANNOUNCES AUTHORIZED GENERIC AGREEMENT WITH HIKMA PHARMACEUTICALS USA INC. FOR NUCYNTA® AND NUCYNTA® ER
COLLEGIUM: HIKMA WILL HAVE EXCLUSIVE RIGHT TO SELL AUTHORIZED GENERIC VERSIONS OF NUCYNTA & NUCYNTA ER IN U.S.

Source text for Eikon: ID:nGNX7yGX8W

Further company coverage: COLL.O

((Reuters.Briefs@thomsonreuters.com;))

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.